caffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution

RxCUI
1994320
RxNorm name
caffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution
Term type
SCD
Status
Active
Updated
2026-11-04 11:31:38

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022018
Active start
022018
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
caffeine2.17 MG / 1 MLcaffeinecaffeine
choline salicylate29 MG / 1 MLcholinecholine salicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
choline2449

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
58809-389-0858809-389TEXACLEAR PAIN RELIEVER Caffeine, Choline salicylateGM Pharmaceuticals, INCM013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01358809-389TEXACLEAR PAIN RELIEVER Caffeine, Choline salicylateOTC MONOGRAPH DRUGGM Pharmaceuticals, INC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
58809038908rxnav_ndcsyes
36800051834rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TEXACLEAR PAIN RELIEVERCAFFEINE, CHOLINE SALICYLATEGM Pharmaceuticals, INC065bd10c-3bcf-486f-a49c-40544127007f2025-10-15WarningsExact identifier
ndc (package): 58809-389-08
ndc (product): 58809-389
ndc11 (package): 58809038908
rxcui: 1994320

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
065bd10c-3bcf-486f-a49c-40544127007fcaffeine 65 MG / choline salicylate 870 MG in 30 mL Oral Solution [PSN] · caffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution [SCD] · caffeine 65 MG / choline salicylate 870 MG per 30 ML Oral Solution [SY]310TEXACLEAR PAIN RELIEVER 8 oz20251015
fee15739-13ef-4ff3-b989-680c732af024caffeine 65 MG / choline salicylate 870 MG in 30 mL Oral Solution [PSN] · caffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution [SCD] · caffeine 65 MG / choline salicylate 870 MG per 30 ML Oral Solution [SY]31TOPCARE PAIN RELIEVER SIMPLE RELIEF20160628

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
065bd10c-3bcf-486f-a49c-40544127007fTEXACLEAR PAIN RELIEVER 8 ozGM Pharmaceuticals, INC20251015
065bd10c-3bcf-486f-a49c-40544127007fTEXACLEAR PAIN RELIEVER 8 ozGM Pharmaceuticals, INC | Sovereign Pharmaceuticals, LLC20241007
fee15739-13ef-4ff3-b989-680c732af024TOPCARE PAIN RELIEVER SIMPLE RELIEFTOPCO ASSOCIATES LLC20160628

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN02BASalicylic acid and derivativesATC1-4choline salicylate
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD002794CholineCHEMhas_ingredientcholine
MEDRTD002794CholineCHEMhas_ingredientcholine salicylate
MEDRTD004338Drug CombinationsCHEMhas_ingredientcholine salicylate
MEDRTD012459SalicylatesCHEMhas_ingredientcholine salicylate
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treatcholine salicylate
MEDRTD002796Choline DeficiencyDISEASEmay_treatcholine
MEDRTD002796Choline DeficiencyDISEASEmay_preventcholine
MEDRTD004342Drug HypersensitivityDISEASEci_withcholine salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withcholine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD007228Infant Nutrition DisordersDISEASEmay_preventcholine
MEDRTD010003OsteoarthritisDISEASEmay_treatcholine salicylate
MEDRTD010146PainDISEASEmay_treatcholine salicylate
MEDRTD011247PregnancyDISEASEci_withcholine salicylate
MEDRTD012213Rheumatic FeverDISEASEmay_treatcholine salicylate
MEDRTN0000000142Biological Macromolecular ActivityMOAhas_moacholine
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moacholine salicylate
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008337Cellular Activity AlterationPEhas_pecholine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pecholine salicylate
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_pecholine salicylate
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH2.17 MG/ML / 29 MG/ML (expressed as choline salicylate)
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymcaffeine 65 MG / choline salicylate 870 MG in 30 mL Oral Solution
SOURCESSourceMetathesaurus FDA Structured Product Labels